Archer transfers biochip graphene sensor technology design to a commercial fab to verify scalability
Archer Materials has successfully completed a proof of concept biosensing graphene transistor for use in its biochip. The design has been submitted to a commercial foundry for a Multi-Project Wafer ...
Researchers have developed a novel, automated device capable of diagnosing glioblastoma, a fast-growing and incurable brain cancer, in less than an hour. The average glioblastoma patient survives ...
In total, the device includes three parts: an automation interface, a prototype of a portable machine that administers materials to run the test and the biochip. Each test requires a new biochip, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results